Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

by | Dec 18, 2025 | Clinical Trials | 0 comments

​ Conditions: Clostridioides Difficile Infection

Interventions: Drug: AZD5148; Other: Placebo

Sponsors: AstraZeneca

Recruiting Conditions: Clostridioides Difficile Infection
Interventions: Drug: AZD5148; Other: Placebo
Sponsors: AstraZeneca
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *